Specialty Pharmacy

Research may lead to new treatment approach for cancer.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC discusses the use of technology to optimize clinical services in specialty pharmacy.

Interstitial lung disease may also precede the first symptoms of IBD.

Interventions needed to get MS patients more active.

Combination of treatments may slow disease progression.

Top stories from last week in oncology drug development.

Sending patients home with information from their files can reinforce pertinent information.

Most read HCV articles of the year.

Most read HIV articles from the past year.

Catch up with the most popular articles from the print journal of Specialty Pharmacy Times this year.

Human pegivirus-2 found only in patients with hepatitis C.

Taking drug around periods of sexual activity lowers transmission rates.

Dr. Raymond Schinazi under fire over HCV drug costs.

Pharmacists can help inform their patients with young children about a few ways to reduce their kids' risk of developing asthma.

Pharmacists may want to encourage their patients with chronic obstructive pulmonary disease to complement their pharmacologic treatment with music therapy.

Pharmacists should familiarize themselves with how much each prescription cost the US government per patient last year.

Sanofi has submitted a new drug application to the FDA for a fixed-ratio combination of insulin glargine and lixisenatide.

An HIV pre-exposure prophylaxis program piloted at a pharmacy in Seattle shows promising results for patients.

Catch up with the most popular articles from the last year.

Keytruda acts by allowing T cells to recognize and attack cancer cells.

Overlap has been assumed to be due to large and especially small airway remodeling.

Study is the first to demonstrate a strong association between HCV and PD.

Early trial shows potential of stem cell transplant combined and high-dose chemotherapy.

Catch up with any news you may have missed this month.

Protein linked to diabetic enteropathy.

Researchers explore alternate treatment for chronic lymphocytic leukemia.

Top news of the week in cancer drug development.

A majority of bowel cancers could be classified into four major categories defined by the researchers.